AI assistant
Catheter Precision, Inc. — Director's Dealing 2023
Mar 27, 2023
35479_dirs_2023-03-27_546d1704-44be-4a3c-9f22-a873b9e2e69c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Ra Medical Systems, Inc. (RMED)
CIK: 0001716621
Period of Report: 2023-03-23
Reporting Person: JENKINS DAVID A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-23 | Common Stock | C | 277597 | — | Acquired | 277597 | Direct |
| 2023-03-23 | Common Stock | C | 709703 | — | Acquired | 709703 | Indirect |
| 2023-03-23 | Common Stock | C | 2264 | — | Acquired | 2264 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-03-23 | Series X Convertible Preferred Stock | $0 | C | 277.597 | Disposed | Common Stock (2292339) | Direct | |
| 2023-03-23 | Series X Convertible Preferred Stock | $0 | C | 709.703 | Disposed | Common Stock (5860540) | Indirect | |
| 2023-03-23 | Series X Convertible Preferred Stock | $0 | C | 2.264 | Disposed | Common Stock (18691) | Indirect |
Footnotes
F1: This transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval.
F2: Shares held by a partnership of which the reporting person is the managing member of the managing partner.
F3: Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee.
F4: Each share of preferred stock will automatically convert into 1000 shares of common stock on or after July 9, 2024, if the Company satisfies the initial listing standards of a national securities exchange or has been delisted from the NYSE American.
F5: Series X Convertible Preferred Stock has no expiration date.